Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 17, 2016 - Issue 9
Submit an article Journal homepage
408
Views
13
CrossRef citations to date
0
Altmetric
Review

Emerging therapeutics in refractory renal cell carcinoma

Vadim S. KoshkinDepartment of Hematology and Oncology, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA
&
Brian I. RiniDepartment of Hematology and Oncology, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USACorrespondence[email protected]
Pages 1225-1232 | Received 07 Mar 2016, Accepted 22 Apr 2016, Published online: 23 May 2016

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Yu-Chi Chen, Bu-Miin Huang, Wei-Chang Lee & Yung-Chia Chen. (2018) 16-Hydroxycleroda-3,13-dien-15,16-olide induces anoikis in human renal cell carcinoma cells: involvement of focal adhesion disassembly and signaling. OncoTargets and Therapy 11, pages 7679-7690.
Read now

Articles from other publishers (12)

Reshma Murali & Abilash Valsala Gopalakrishnan. (2023) Molecular insight into renal cancer and latest therapeutic approaches to tackle it: an updated review. Medical Oncology 40:12.
Crossref
Juan Jin, Yuhao Xie, Jin-Shi Zhang, Jing-Quan Wang, Shi-Jie Dai, Wen-fang He, Shou-Ye Li, Charles R. AshbyJr.Jr., Zhe-Sheng Chen & Qiang He. (2023) Sunitinib resistance in renal cell carcinoma: From molecular mechanisms to predictive biomarkers. Drug Resistance Updates 67, pages 100929.
Crossref
Carla Climent, Sandra Soriano, Teresa Bonfill, Natalia Lopez, Marta Rodriguez, Marina Sierra, Pablo Andreu, Monica Fragio, Mireia Busquets, Alicia Carrasco, Ona Cano, Miguel-Angel Seguı́ & Enrique Gallardo. (2023) The role of immunotherapy in non-clear cell renal cell carcinoma. Frontiers in Oncology 13.
Crossref
Alec Sundet, Jodi McConnell, Kyle Walker & Bennie Lindeque. (2021) Intraoperative Cryotherapy in the Treatment of Metastatic Renal Cell Carcinoma of the Bone. Orthopedics 44:5.
Crossref
Bo’ang Han, Zhen Sun, Tingting Yu, Yu Wang, Lun Kuang, Tianyuan Li, Jing Cai, Qing Cao, Yuan Xu, Binbin Gao, Steven Y. Cheng, Shen Yue & Chen Liu. (2021) SPOP–PTEN–SUFU axis promotes progression of clear cell renal cell carcinoma via activating SHH and WNT pathway. Cell Death Discovery 7:1.
Crossref
Lixia Wang, Min Lin, Man Chu, Yi Liu, Jia Ma, Youhua He & Zhi-wei Wang. (2020) SPOP promotes ubiquitination and degradation of LATS1 to enhance kidney cancer progression. EBioMedicine 56, pages 102795.
Crossref
Fatemeh K. Dermani, Pouria Samadi, Golebagh Rahmani, Alisa K. Kohlan & Rezvan Najafi. (2018) PD‐1/PD‐L1 immune checkpoint: Potential target for cancer therapy. Journal of Cellular Physiology 234:2, pages 1313-1325.
Crossref
Vadim S. Koshkin, Pedro C. Barata, Tian Zhang, Daniel J. George, Michael B. Atkins, William J. Kelly, Nicholas J. Vogelzang, Sumanta K. Pal, JoAnn Hsu, Leonard J. Appleman, Moshe C. Ornstein, Timothy Gilligan, Petros Grivas, Jorge A. Garcia & Brian I. Rini. (2018) Clinical activity of nivolumab in patients with non-clear cell renal cell carcinoma. Journal for ImmunoTherapy of Cancer 6:1.
Crossref
N. E. Kushlinskii, M. V. Fridman, A. A. Morozov, E. S. Gershtein, Z. G. Kadagidze & V. B. Matveev. (2018) Modern approaches to kidney cancer immunotherapy. Cancer Urology 14:2, pages 54-67.
Crossref
Kevin Zarrabi, Chunhui Fang & Shenhong Wu. (2017) New treatment options for metastatic renal cell carcinoma with prior anti-angiogenesis therapy. Journal of Hematology & Oncology 10:1.
Crossref
Pedro C. Barata & Brian I. Rini. (2017) Treatment of renal cell carcinoma: Current status and future directions. CA: A Cancer Journal for Clinicians 67:6, pages 507-524.
Crossref
Wencai Zhao, Jiancheng Zhou, Zhuo Deng, Yang Gao & Yongyi Cheng. (2016) SPOP promotes tumor progression via activation of β-catenin/TCF4 complex in clear cell renal cell carcinoma. International Journal of Oncology.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.